Together, our analysis and previous research suggests that LY6D expression may indicate a more aggressive pancreatic cancer phenotype and it would therefore be beneficial to explore the precise mechanism of action for LY6D to determine its therapeutic potential. The gene discussed is LY6D; the disease is familial pancreatic carcinoma.